Uniting Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Sell
5,540
-277
-5% -$64.6K 0.29% 59
2026
Q1
$1.42M Sell
5,817
-140
-2% -$32.6K 0.3% 54
2025
Q4
$1.23M Buy
5,957
+901
+18% +$178K 0.38% 44
2025
Q3
$938K Buy
+5,056
New +$866K 0.22% 67

Other funds holding JNJ

Uniting Wealth Partners's JNJ Position: Q2 2026 in Review

Uniting Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 4.8% in Q2 2026, selling an estimated $64.6K and leaving 5,540 shares worth $1.41M. The position accounts for 0.29% of the portfolio, ranked #59.

Uniting Wealth Partners first reported a position in JNJ in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.42M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Uniting Wealth Partners held 5,540 shares of Johnson & Johnson worth $1.41M as of Q2 2026.
  • Uniting Wealth Partners sold 277 Johnson & Johnson shares in Q2 2026, an estimated $64.6K.
  • Johnson & Johnson made up 0.29% of Uniting Wealth Partners's portfolio in Q2 2026, its #59 holding.
  • Uniting Wealth Partners first reported a position in Johnson & Johnson in Q3 2025 and has held it in 4 quarters since.
  • Uniting Wealth Partners's Johnson & Johnson position peaked at $1.42M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Uniting Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.